Priapism in an infant with sickle cell trait after cardiac transplant

Chasta-Dawne Bacsu1, Peter D Metcalfe

  • 1Division of Urology, University of Alberta, Edmonton, Alberta, Canada.

Urology
|August 21, 2012
PubMed

Insights

A case study found that a 6-month-old boy experienced prolonged erections after receiving intravenous sildenafil for pulmonary hypertension post-cardiac transplant. The sickle cell trait may have contributed to this side effect.

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Genetics

Background:

  • A 6-month-old boy underwent orthotopic cardiac transplantation after receiving a Berlin heart.
  • Postoperative pulmonary hypertension necessitated treatment with intravenous sildenafil, a phosphodiesterase-5 inhibitor.
  • The patient required multiple transfusions during pre-, peri-, and postoperative care.

Purpose of the Study:

  • To report a case of priapism in an infant treated with sildenafil.
  • To investigate potential contributing factors to priapism in this patient.
  • To highlight the side effect profile of sildenafil in pediatric cardiac patients.

Main Methods:

  • Case report of a 6-month-old boy of African descent.
  • Clinical observation of prolonged, semitumescent erections.
  • Genetic testing for sickle cell trait.
  • Review of medication and medical history.

Main Results:

  • The patient developed recurrent prolonged erections (30-180 minutes) during intravenous sildenafil therapy.
  • Erections resolved spontaneously without urologic intervention.
  • The patient was identified as a carrier of the sickle cell gene.

Conclusions:

  • Sildenafil use in conjunction with the sickle cell trait may be linked to priapism in pediatric patients.
  • This case highlights a potential adverse effect of sildenafil in infants post-cardiac surgery.
  • Further research is needed to understand the interaction between sildenafil and sickle cell trait in children.

Related Concept Videos